🔥 Black Friday Sale: Save 30% or more on all Examine products Learn more »

Studies related to Psoriasis and Polypodium leucotomos

A New Agent (hydrophilic Fraction Of Polypodium Leucotomos) For Management Of Psoriasis

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 63
Sex n/a
Notes for this study:
Clinical signs of Psoriasis were reduced after consuming of Polypodium, but exact dose was not known; out of 31 subjects in experimental group, there were 3 nonresponders and 7 with modest benefit.